Dianabol

Methandrostenolone acts primarily through androgen receptor activation, altering gene expression in androgen-responsive tissues.

Key pharmacological characteristics include:

Protein metabolism: Influences protein synthesis and nitrogen retention, processes associated with changes in lean tissue.

Muscle development: Can promote increases in body mass and muscular strength.

Androgen receptor signaling: Modulates androgen-responsive pathways in skeletal muscle and other tissues.

Estrogenic activity: Can undergo aromatization to estrogenic metabolites, potentially contributing to fluid retention and estrogen-related adverse effects.

Endocrine suppression: Can inhibit hypothalamic-pituitary-gonadal signaling, reducing endogenous testosterone production.

Methandrostenolone has been associated with increases in body weight, strength, and lean body mass. However, changes in body weight may also reflect fluid retention rather than increases in contractile muscle tissue alone.

The magnitude and composition of these changes vary according to individual physiology, exposure, nutritional status, and other factors. Reported performance effects should not be interpreted as evidence of long-term safety.